Home  >  Products  >  Rpl23a (ribosomal protein L23A ) Blocking Peptide (the C terminal of Rpl23a)(100ug)
Rpl23a (ribosomal protein L23A ) Blocking Peptide (the C terminal of Rpl23a)(100ug)

Rpl23a (ribosomal protein L23A ) Blocking Peptide (the C terminal of Rpl23a)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-RPL23A Antibody (ARP61966_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP61966
Size: 100ug
Weight: 18kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a ribosomal protein that is a component of the 60S subunit. The protein belongs to the L23P family of ribosomal proteins. It is located in the cytoplasm. The protein may be one of the target molecules involved in mediating growth inhibition by interferon. In yeast, the corresponding protein binds to a specific site on the 26S rRNA. This gene is co-transcribed with the U42A, U42B, U101A, and U101B small nucleolar RNA genes, which are located in its third, first, second, and fourth introns, respectively. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome.
Alternative names: FLJ27455; MDA20